Markus Fluck

896 total citations
25 papers, 765 citations indexed

About

Markus Fluck is a scholar working on Spectroscopy, Oncology and Analytical Chemistry. According to data from OpenAlex, Markus Fluck has authored 25 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Spectroscopy, 6 papers in Oncology and 5 papers in Analytical Chemistry. Recurrent topics in Markus Fluck's work include Analytical Chemistry and Chromatography (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Markus Fluck is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Markus Fluck collaborates with scholars based in Germany, United States and Switzerland. Markus Fluck's co-authors include Volker Schurig, Martin Jung, Alexandra Glausch, Lauren Sompayrac, Jean Feunteun, T L Benjamin, Karin Cabrera, Sabine Mayer, Graeme Nicholson and Róbert Hermann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Journal of Chromatography A.

In The Last Decade

Markus Fluck

25 papers receiving 713 citations

Peers

Countries citing papers authored by Markus Fluck

Since Specialization

Citations

This map shows the geographic impact of Markus Fluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Fluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Fluck more than expected).

Fields of papers citing papers by Markus Fluck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Fluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Fluck. The network helps show where Markus Fluck may publish in the future.

Co-authorship network of co-authors of Markus Fluck

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Fluck. A scholar is included among the top collaborators of Markus Fluck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Fluck. Markus Fluck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), Sathej Gopalakrishnan, Özkan Yalkinoglu, (unknown), Hong Lü, Kosalaram Goteti, Axel Krebs‐Brown, (unknown), Ulrike Gradhand, Markus Fluck, (unknown), Jennifer Dong, Karthik Venkatakrishnan	13
2	Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine 2021 ·Clinical Pharmacokinetics ·Róbert Hermann, Péter Krajcsi, Markus Fluck, (unknown), (unknown), Andrew Galazka, Alain Munafo	6
3	Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions 2021 ·Clinical Pharmacokinetics ·Róbert Hermann, Péter Krajcsi, Markus Fluck, (unknown), (unknown), Andrew Galazka, Alain Munafo	9
4	Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION 2021 ·Journal of Neuroimmunology ·Mark S. Freedman, Jérôme Wojcik, Kristina Holmberg, Markus Fluck, M. D'Antonio, Yann Hyvert, Sofia Stinchi, (unknown), Fernando Dangond	5
5	195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding 2020 ·Regular and Young Investigator Award Abstracts ·Hulin Jin, (unknown), Berend Neuteboom, Sean D. McKenna, (unknown), Alec W. Gross, (unknown), Lars Toleikis, Markus Fluck, (unknown), Ti Cai	2
6	The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis 2018 ·Clinical Pharmacokinetics ·Róbert Hermann, Mats O. Karlsson, Ana Novaković, Nadia Terranova, Markus Fluck, Alain Munafo	53
7	In Vitro Characterization of Sarizotan Metabolism: Hepatic Clearance, Identification and Characterization of Metabolites, Drug-Metabolizing Enzyme Identification, and Evaluation of Cytochrome P450 Inhibition 2010 ·Drug Metabolism and Disposition ·(unknown), (unknown), (unknown), Achim Freisleben, Markus Fluck, B. Ladstetter, Hugues Dolgos	5
8	Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·Sonja Krösser, J. Tillner, Markus Fluck, (unknown), (unknown), (unknown)	6
9	Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial 2006 ·European Journal of Clinical Pharmacology ·Sonja Krösser, (unknown), Hugues Dolgos, Markus Fluck, (unknown), Andreas Kovar	23
10	Enantiomer separation by complexation SFC on immobilized Chirasil-nickel and Chirasil-zinc 2000 ·Journal of Biochemical and Biophysical Methods ·Volker Schurig, Markus Fluck	20
11	3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist 1998 ·Bioorganic & Medicinal Chemistry Letters ·Werner W. K. R. Mederski, Dieter Dorsch, (unknown), Soheila Anzali, (unknown), (unknown), P. Schelling, Claudia Wilm, Markus Fluck	9
12	Dynamic phenomena involving chiral dimethyl-2,3-pentadienedioate in enantioselective gas chromatography and NMR spectroscopy 1997 ·Tetrahedron Asymmetry ·Volker Schurig, (unknown), Sabine Reich, Markus Fluck	24
13	ChemInform Abstract: The Enantiomerization Barrier of Atropisomeric 2,2′,3,3′,4,6′‐ Hexachlorobiphenyl (PCB 132). 1996 ·ChemInform ·Volker Schurig, Alexandra Glausch, Markus Fluck	3
14	Unified enantioselective capillary chromatography on a Chirasil-DEX stationary phase Advantages of column miniaturization 1995 ·Journal of Chromatography A ·Volker Schurig, Martin Jung, Sabine Mayer, Markus Fluck, (unknown), (unknown)	82
15	On the enantiomerization barrier of atropisomeric 2,2′,3,3′,4,6′-hexachlorobiphenyl (PCB 132) 1995 ·Tetrahedron Asymmetry ·Volker Schurig, Alexandra Glausch, Markus Fluck	62
16	Enantiomer Separation by Capillary SFC and GC on Chirasil-Nickel: Observation of Unusual Peak Broadening Phenomena 1994 ·Analytical Chemistry ·Michael Schleimer, Markus Fluck, Volker Schurig	21
17	Enantioselektive Trennung von Hexobarbital durch GC, SFC, LC und CEC an einer mit Chirasil‐Dex belegten Kapillarsäule 1994 ·Angewandte Chemie ·Volker Schurig, Martin Jung, Sabine Mayer, (unknown), Markus Fluck, (unknown)	19
18	Separation of the enantiomers of stable atropisomeric polychlorinated biphenyls (PCBs) by multidimensional gas chromatography on Chirasil‐Dex 1994 ·Journal of High Resolution Chromatography ·Alexandra Glausch, Graeme Nicholson, Markus Fluck, Volker Schurig	58
19	Toward Unified Enantioselective Chromatography with a Single Capillary Column Coated with Chirasil‐Dex 1994 ·Angewandte Chemie International Edition in English ·Volker Schurig, Martin Jung, Sabine Mayer, (unknown), Markus Fluck, (unknown)	26
20	Localization of gene functions in polyoma virus DNA. 1976 ·Proceedings of the National Academy of Sciences ·Jean Feunteun, Lauren Sompayrac, Markus Fluck, T L Benjamin	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact